What Is Continuous Glucose Monitoring?

Continuous Glucose Monitoring (CGM) represents a significant advancement in diabetes care technology. Unlike traditional blood glucose meters that provide single readings at specific moments, CGM systems track glucose levels throughout the day and night, offering a comprehensive view of how blood sugar changes over time.

These systems consist of three main components: a small sensor inserted under the skin, a transmitter attached to the sensor, and a receiver or compatible smart device that displays the data. The sensor measures glucose levels in the interstitial fluid—the fluid surrounding cells—rather than directly from the bloodstream. While this creates a slight lag (about 5-15 minutes) behind actual blood glucose levels, the continuous nature of the readings provides valuable information about trends and patterns that spot tests cannot capture.

How Dexcom CGM Technology Works

Dexcom has established itself as a leading provider in the CGM market with its user-friendly systems designed for people with diabetes. The current flagship product, the Dexcom G6 (with G7 now available in some markets), offers features that make glucose monitoring more convenient and informative.

The Dexcom sensor uses a tiny wire inserted just under the skin, typically on the abdomen or upper arm. This sensor measures glucose levels every few minutes and sends this data wirelessly to a receiver or smartphone. The system provides real-time glucose readings, directional trends, and customizable alerts for high or low glucose levels.

One of the most valuable aspects of Dexcom's technology is its sharing capabilities. Users can share their glucose data with up to ten followers—family members, caregivers, or healthcare providers—who can remotely monitor readings through the Dexcom Follow app. This feature provides peace of mind for parents of children with diabetes and for adults who may need assistance managing their condition.

CGM Provider Comparison

While Dexcom is prominent in the CGM market, several other manufacturers offer alternatives with different features and benefits. Understanding these options helps users make informed decisions based on their specific needs.

Dexcom G6/G7: Dexcom offers 10-day sensor wear, no fingerstick calibration, and direct integration with insulin pumps and smartphones. The G7 model features a smaller, all-in-one design with a 30-minute warm-up period compared to the G6's two hours.

Abbott FreeStyle Libre: Abbott's FreeStyle Libre system uses a different approach called Flash Glucose Monitoring, where users scan the sensor with a reader or smartphone to get current readings rather than having continuous automatic transmission. The newer Libre 2 and 3 models include optional alarms for high and low glucose levels. Sensors typically last 14 days.

Medtronic Guardian: Medtronic's Guardian Connect system integrates directly with their insulin pumps for automated insulin delivery. The sensors require calibration with fingerstick readings and typically last 7 days.

Eversense: Eversense offers a unique implantable CGM sensor that lasts up to 180 days, inserted and removed by a healthcare provider during an in-office procedure. It requires twice-daily calibration but eliminates frequent sensor changes.

Benefits of Using Dexcom CGM Systems

Continuous glucose monitoring through systems like Dexcom provides numerous advantages for diabetes management that extend beyond convenience.

Improved Glycemic Control: Studies published in diabetes journals show that CGM users often achieve better HbA1c levels (a measure of average blood glucose over 2-3 months) compared to those using only traditional fingerstick monitoring. The continuous data helps users make more timely adjustments to insulin dosing, diet, and exercise.

Reduced Hypoglycemia Risk: One of the most significant benefits is the ability to set alerts for dropping glucose levels before they reach dangerously low points. This predictive capability helps prevent severe hypoglycemic episodes, especially during sleep when symptoms might otherwise go unnoticed.

Pattern Recognition: With continuous data collection, users and healthcare providers can identify patterns and triggers that affect glucose levels. This insight allows for more personalized treatment plans and lifestyle adjustments tailored to individual responses.

Reduced Testing Burden: Modern CGM systems like the Dexcom G6 are factory-calibrated, eliminating or significantly reducing the need for fingerstick tests. This reduces both the physical discomfort and the mental burden of diabetes management.

Considerations and Cost Factors

While CGM technology offers substantial benefits, potential users should consider several factors when deciding if it's right for them.

Insurance Coverage: Coverage for CGM systems varies widely among insurance providers. Many now cover CGM for people with Type 1 diabetes, while coverage for Type 2 diabetes may depend on specific criteria such as insulin use or history of hypoglycemia unawareness. Dexcom and other manufacturers typically offer insurance verification services to help determine coverage.

Out-of-Pocket Costs: Without insurance coverage, CGM systems represent a significant investment. The initial cost includes the transmitter (approximately $200-300) plus ongoing expenses for sensors (around $300-400 per month). Some manufacturers offer subscription programs to help manage costs.

Wearability Concerns: Users must be comfortable wearing the sensor on their body continuously. While modern sensors are smaller and more discreet than earlier versions, they still require adhesive attachment to the skin, which can cause irritation for some people.

Technical Considerations: CGM systems require basic technological proficiency, especially when using smartphone apps and sharing features. Users need compatible smartphones and reliable internet connections to maximize the benefits of these systems.

The American Diabetes Association recognizes CGM as a valuable tool for diabetes management, particularly for insulin users. Healthcare providers can help determine if CGM is appropriate based on individual health needs, lifestyle, and insurance coverage.

Conclusion

Continuous Glucose Monitoring systems like those from Dexcom have transformed diabetes management from isolated snapshots to a comprehensive, real-time understanding of glucose patterns. While the technology represents an investment in both cost and adaptation, the benefits of improved control, reduced hypoglycemia risk, and data-driven decision-making make it a valuable consideration for many people with diabetes. As technology continues to advance, these systems will likely become even more accessible, accurate, and integrated with other diabetes management tools. For those considering CGM, consulting with healthcare providers and insurance companies is an important first step toward determining if this technology aligns with individual needs and circumstances.

Citations

This content was written by AI and reviewed by a human for quality and compliance.